$26.80 $0.44 per serving
Product analysis
QH-absorb 100 mg provides CoQ10 at a favorable cost and may support blood-vessel function in selected people. Benefits for routine energy are less certain and depend on the preparation used.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
Incomplete CoQ10 form details limit a confident quality comparison. The product name alone does not establish an absorption advantage.
Ingredient Transparency63
The CoQ10 amount is stated, making the serving clear. Incomplete form details limit comparisons between preparations.
Value For Money100
The CoQ10 offers favorable value for the amount supplied. That cost advantage does not establish stronger health effects.
Customer Satisfaction88
Customer feedback is strongly positive across thousands of ratings. The broad response base describes satisfaction without proving effectiveness.
Product Focus73
The formula keeps its focus on a single active ingredient. Blood-vessel support has the clearest connection, while energy and other benefits remain more uncertain.
- Format
Softgel - Container
- 60 Softgel(s)
- Per serving
- $0.44
- Also available
QH-absorb 100 mg$42.70- Customer rating
- 4.7 · 3,995 ratings
Goals
Impact
Highest effect
Coenzyme Q-10 · 100 mg
Ubiquinol may support blood-vessel widening. The declared 100 mg per serving matches an exposure studied in adults with abnormal blood lipids and impaired vessel function. The small trial found improved widening, without establishing fewer cardiovascular events or a benefit for everyone. Matching the active identity does not prove equivalence of the finished product.
How this product is rated for Heart Health
Ingredient fit93
Ubiquinol provides a focused connection to blood-vessel function. The 100 mg ubiquinol serving matches a supplied trial exposure.
Goal fit
Ubiquinol provides a focused connection to blood-vessel function.
Dose adequacy
The 100 mg ubiquinol serving matches a supplied trial exposure.
Pathways60
The saved findings concentrate on blood-vessel widening.
Depth
Ubiquinol supplies the finding on blood-vessel widening.
Breadth
Only the vascular aspect meets the coverage criterion.
Evidence98
Ubiquinol has small-trial evidence in a selected population. The declared ubiquinol matches the supported identity, without proving finished-product equivalence.
Evidence strength
Ubiquinol has small-trial evidence in a selected population.
Studied preparation
The declared ubiquinol matches the supported identity, without proving finished-product equivalence.
Formulation logic100
No missing required partner or specified ingredient conflict was identified. The counted amounts meet the minimum criterion.
Partner coverage
The counted ingredients have no missing required partner.
Conflicts
No specified ingredient conflict was identified in the supplied facts.
Effective doses
All counted ingredients meet the minimum amount criterion; this does not establish a clinical benefit.
Impact
High effect
Coenzyme Q-10 · 100 mg
CoQ10 participates in mitochondrial energy production and has limited, preparation-specific evidence concerning fatigue. This serving provides 100 mg, but its declaration does not identify ubiquinol or ubiquinone. The saved findings count a contribution, while the unresolved form limits how confidently preparation-specific fatigue results can be applied.
How this product is rated for Energy
Ingredient fit73
CoQ10 provides a counted contribution, with amounts meeting the saved comparison to differing degrees.
Goal fit
CoQ10 supplies the focused contribution in the saved findings.
Dose adequacy
The declared amount meets part of the saved comparison, without establishing a proven fatigue-treatment dose.
Pathways40
The saved contribution is concentrated in mitochondrial energy production.
Depth
Mitochondrial energy production is the strongest tracked area.
Breadth
Only mitochondrial energy production reaches the breadth comparison.
Evidence95
CoQ10 has limited fatigue evidence that depends on preparation and population; disease-cohort findings do not establish routine benefit in healthy adults.
Evidence strength
CoQ10 has limited fatigue evidence that depends on preparation and population; disease-cohort findings do not establish routine benefit in healthy adults.
Studied preparation
The saved findings accept CoQ10's preparation, but the generic declaration leaves its redox form unresolved.
Formulation logic100
CoQ10 needs no additional partner for the counted contribution. No configured ingredient conflict was matched.
Partner coverage
The counted ingredients can contribute without an additional partner.
Conflicts
No configured ingredient conflict was matched.
Effective doses
All counted ingredients reach the saved minimum amount comparison.
Impact
Highest effect
Coenzyme Q-10 · 100 mg
Ubiquinol has limited support for blood-vessel lining measures in people with abnormal lipids and endothelial dysfunction. The declared preparation receives full amount recognition, without establishing a greater effect from larger servings. Its findings do not establish superiority over ubiquinone or routine prevention of cardiovascular events, and benefits from treated heart-failure studies cannot be assumed here.
How this product is rated for Cardiovascular Support
Ingredient fit93
Coenzyme Q-10 is the main recognized ingredient; its disclosed serving receives full amount recognition.
Goal fit
The recognized ingredients dominate the formula, with links to other goals reducing its cardiovascular specificity.
Dose adequacy
The disclosed serving receives full amount recognition, which does not establish greater benefit or a personal dose requirement.
Pathways60
The strongest assigned contribution concerns endothelial nitric-oxide function. Other cardiovascular mechanisms have less or no assigned coverage.
Depth
The strongest assigned support concerns endothelial nitric-oxide function, rather than comprehensive cardiovascular protection.
Breadth
Only endothelial nitric-oxide function reaches the coverage threshold.
Evidence88
Coenzyme Q-10 leads the evidence findings. The supplied population and preparation limits remain relevant to expectations.
Evidence strength
Coenzyme Q-10 provides the leading evidence contribution; its marker findings do not establish prevention of cardiovascular events.
Studied preparation
The counted preparations are recognized as studied, with the population and exposure distinctions described for the relevant ingredients.
Formulation logic100
The counted ingredients have no unmet partner requirement or identified configured conflict; amount thresholds are considered separately.
Partner coverage
No unmet partner requirement is identified for the counted ingredients; combining them does not establish an added benefit.
Conflicts
No configured ingredient conflict was identified.
Effective doses
All counted ingredients clear the minimum amount threshold, which is distinct from a proven effective dose.
Impact
Moderate effect
Coenzyme Q-10 · 100 mg
CoQ10 supports cellular energy production and antioxidant functions. Its 100 mg amount provides partial exposure support, but the relevant skin-aging trial used a specific water-soluble preparation, limiting direct comparison.
How this product is rated for Longevity
Ingredient fit73
The counted ingredients are closely aligned with the aging-related functions assessed here. The counted amounts provide partial exposure support.
Goal fit
The counted ingredients are closely aligned with the aging-related functions assessed here.
Dose adequacy
The counted amounts provide partial exposure support.
Pathways10
The strongest supported mechanism is mitochondrial energy production, with limited coverage. No mechanism reaches the saved coverage target.
Depth
The strongest supported mechanism is mitochondrial energy production, with limited coverage.
Breadth
No mechanism reaches the saved coverage target.
Evidence30
Coenzyme Q-10 provides the strongest evidence contribution among ingredients counted at a sufficient amount, within the limited outcomes supplied. The counted preparation is not matched to the preparation used in the relevant supplied trials.
Evidence strength
Coenzyme Q-10 provides the strongest evidence contribution among ingredients counted at a sufficient amount, within the limited outcomes supplied.
Studied preparation
The counted preparation is not matched to the preparation used in the relevant supplied trials.
Formulation logic100
The counted ingredients can contribute independently or have their required partner. No configured ingredient conflict was identified in the supplied findings. 1 of 1 counted ingredients meet the saved minimum exposure threshold.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
1 of 1 counted ingredients meet the saved minimum exposure threshold.
Impact
Moderate effect
Coenzyme Q-10 · 100 mg
CoQ10 is relevant to oxidative and mitochondrial stress. The 100 mg ubiquinol serving has limited evidence for inflammation support, and the reviewed ubiquinone findings cannot be assumed to apply equally to this form.
How this product is rated for Inflammation
Ingredient fit73
The relevant ingredients give the formula a clear inflammation-related focus. The assessed amounts provide a partial match to the saved dose comparisons.
Goal fit
The relevant ingredients give the formula a clear inflammation-related focus.
Dose adequacy
The assessed amounts provide a partial match to the saved dose comparisons.
Pathways19
The strongest assessed connection is to oxidative and mitochondrial stress, with limited coverage in the saved findings. The saved findings show limited breadth across the main inflammation mechanisms.
Depth
The strongest assessed connection is to oxidative and mitochondrial stress, with limited coverage in the saved findings.
Breadth
The saved findings show limited breadth across the main inflammation mechanisms.
Evidence63
Coenzyme Q-10 provides the strongest assessed evidence in the formula, with relevant but qualified support for this goal. The assessed CoQ10 preparation does not match the preparation supporting the saved inflammation evidence.
Evidence strength
Coenzyme Q-10 provides the strongest assessed evidence in the formula, with relevant but qualified support for this goal.
Studied preparation
The assessed CoQ10 preparation does not match the preparation supporting the saved inflammation evidence.
Formulation logic100
All assessed contributors meet the saved minimum amount comparison. No ingredient conflicts were identified in the saved assessment.
Partner coverage
The assessed ingredients can contribute independently or have their required partner present.
Conflicts
No ingredient conflicts were identified in the saved assessment.
Effective doses
All assessed contributors meet the saved minimum amount comparison.
Impact
High effect
Coenzyme Q-10 · 100 mg
CoQ10 supports the cell's energy-transfer machinery, but this does not show that supplementation increases whole-body calorie use. The supplied studies concern metabolic markers rather than a general metabolism boost. The declared amount receives recognition without establishing sustained thermogenesis or weight loss.
How this product is rated for Metabolism Support
Ingredient fit73
CoQ10 provides a focused single-ingredient formula.
Goal fit
CoQ10 provides a focused single-ingredient formula.
Dose adequacy
CoQ10 receives partial amount recognition rather than reaching its comparison endpoint.
Pathways17
The saved findings place CoQ10 in cellular energy and fat oxidation, with limited coverage.
Depth
Cellular energy and fat oxidation receives partial coverage.
Breadth
No evaluated category reaches the breadth threshold.
Evidence75
CoQ10 leads the retained evidence finding, but cellular energy and metabolic-control findings do not establish a routine metabolism boost.
Evidence strength
CoQ10 leads the retained evidence finding, but cellular energy and metabolic-control findings do not establish a routine metabolism boost.
Studied preparation
Retained preparations with usable amounts are accepted in the saved finding; this does not establish superior effects from particular nutrient forms.
Formulation logic100
No required partner is missing and no configured conflict is triggered. Amount recognition does not establish sustained thermogenesis.
Partner coverage
Retained ingredients require no missing partner; combining them does not establish additional thermogenic benefit.
Conflicts
No configured conflict is triggered, without establishing overall safety or personal suitability.
Effective doses
All 1 retained ingredient meets the comparison amount threshold; this is not proof of a clinically effective thermogenic dose.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Ubiquinol | 100 mg |
Coenzyme Q-10 · 100 mg OverallScore89
1 softgel provides 100 mg of CoQ10 as ubiquinol. The whole-product price is about $0.45 per serving.
How this ingredient is rated
Active Ingredient Quality & Bioavailability72
The saved facts identify ubiquinol, the reduced form of CoQ10. No specified advanced delivery system or black pepper extract is recorded in the saved facts.
Molecular Form: Ubiquinol vs. Ubiquinone
The saved facts identify ubiquinol, the reduced form of CoQ10.
Formulation & Absorption Enhancers
No specified advanced delivery system or black pepper extract is recorded in the saved facts.
Dose, Safety & Label Transparency100
Each serving provides 100 mg of CoQ10. The amount is disclosed, and none of the listed additives or standard fillers are flagged.
Clinical Dosage Alignment
Each serving supplies 100 mg of CoQ10.
Label Transparency & Fillers
The CoQ10 amount is disclosed, and the evaluation flags none of the listed additives or standard fillers.
Value100
The whole-product price is about $0.45 per serving containing 100 mg of CoQ10.
Price Per Effective Serving
The whole-product price is about $0.45 per serving, which contains 100 mg of CoQ10.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
- The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
- [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
- Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
- Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
- Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
- Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Antifatigue effects of coenzyme Q10 during physical fatigue.
- Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
- Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
- Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
- Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
- The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
- The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
- Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
- Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
- Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
- Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.